Drugs / emtricitabine/tenofovir disoproxil fumarate
emtricitabine/tenofovir disoproxil fumarate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00090779 Comparator | Jan 2005 → Jul 2009 | HIV infectious disease | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Terminated | No outcome recorded |
Press releases naming this drug 7 releases
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | emtricitabine/tenofovir disoproxil fumarate | “received emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), coformulated as Truvada” NCT00090779 ↗ |
| Known as | FTC/TDF | “received emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), coformulated as Truvada” NCT00090779 ↗ |
| Known as | Truvada | “received emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), coformulated as Truvada” NCT00090779 ↗ |